Empagliflozin Attenuates Cardiac Fibrosis by Suppressing Fibroblast‐Mediated C‐C Motif Chemokine Ligand 2 Expression
Background Despite recent advances in pharmacotherapy, heart failure (HF) remains a major cause of hospitalization and death, particularly among aging populations. Sodium–glucose cotransporter 2 inhibitors have reduced hospitalization for HF and cardiovascular death. However, the mechanisms underlyi...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2026-02-01
|
| Ráidu: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Fáttát: | |
| Liŋkkat: | https://www.ahajournals.org/doi/10.1161/JAHA.125.043917 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|